Health Care·Life Sciences Tools & Services·$8.5B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.82 | N/A | -2.15% |
management commentary, guidance changes, and full analysis available with Pro.
| -2.15% |
Tone: Defensive
Management expressed concerns about market conditions impacting performance. They remain focused on strategic initiatives for future growth.
Management noted challenges in the current market environment.
They emphasized a focus on long-term growth despite short-term pressures.
Bio-Techne Corp's earnings report showed a slight miss on EPS, leading to a 2.05% drop in stock price. The lack of revenue data and guidance may have contributed to investor uncertainty. Management's cautious tone suggests they are navigating a challenging market environment, which could impact future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
UNUM GROUP
Aug 5, 2013